Forum Πρωτοβάθμιας Φροντίδας Υγείας
ΠΦΥ -Εκπαίδευση => Αποσπάσματα από τον έντυπο & ηλεκτρονικό τύπο => Μήνυμα ξεκίνησε από: Argirios Argiriou στις 28 Μαΐου 2013, 13:54:11
-
BMJ 1996: 312: 1563.
Variability in risk of gastrointestinal complications with individual
non-steroidal anti-inflammatory drugs: results of a collaborative
meta-analysis.
David Henry, Lynette L-Y rim, Luis A Garcia Rodriguez, Susanne Perez Gutthann, Jeffrey L
Carson, Marie Griffin, Ruth Savage, Richard Logan,Yola Moride, Chris Hawkey, Suzanne Hill,
James T Fries
Correspondence to:
Dr David Henry, Centre for
Clinical Epidemiology and
Biostatistics, Royal
Newcastle Hospital,
Newcastle, NSW2300,
Australia.
mddah®alinga.newcastle.
edu.au
................
...........................
Key messages.
* Gastrointestinal complications of treatment with
non-steroidal anti-inflammatory drugs are a major
cause of morbidity and mortality
* Because there are no important differences in
efficacy, choice of first line treatment with these
drugs should be based on their relative toxicity
* Meta-analysis of the available epidemiological
studies shows wide differences between individual
drugs in the risk of inducing gastrointestinal bleeding and ulcer perforation
* Of the drugs in common use, ibuprofen and
diclofenac rank low in toxicity whereas azapropazone, ketoprofen, and piroxicam rank high
* Some of the differences between drugs may be
explained by dose, and the advantage of "low risk"
drugs may be lost once their dose is increased
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2351326/pdf/bmj00547-0015.pdf